Tempest Therapeutics Newsroom

Tempest Therapeutics Analyst Ratings

BenzingaMay 13 08:07 ET

Tempest Therapeutics Analyst Ratings

BenzingaMay 10 15:01 ET

Scotiabank Sticks to Their Buy Rating for Tempest Therapeutics (TPST)

TipRanksMay 10 08:21 ET

Buy Rating Affirmed for Tempest Therapeutics Amidst Promising Clinical Advancements

TipRanksMay 10 06:31 ET

Tempest Therapeutics (TPST) Receives a Buy From Scotiabank

TipRanksMar 20 07:21 ET

Piper Sandler Keeps Their Buy Rating on Tempest Therapeutics (TPST)

TipRanksMar 20 07:21 ET

Tempest Therapeutics Analyst Ratings

BenzingaMar 20 06:41 ET

Tempest Therapeutics Analyst Ratings

BenzingaMar 13 17:27 ET

Buy Rating Affirmed for Tempest Therapeutics Amid Strong TPST-1120 Preclinical and Financial Prospects

TipRanksMar 12 11:10 ET

Tempest Therapeutics Analyst Ratings

BenzingaMar 12 11:03 ET

Tempest Therapeutics Analyst Ratings

BenzingaFeb 8 07:44 ET

Growth Potential and Strategic Partnerships: Reasons for Aydin Huseynov's Buy Rating on Tempest Therapeutics

TipRanksNov 10, 2023 10:16 ET

Piper Sandler Sticks to Their Buy Rating for Tempest Therapeutics (TPST)

TipRanksNov 9, 2023 12:24 ET

Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Atara Biotherapeutics (ATRA) and Tempest Therapeutics (TPST)

TipRanksNov 9, 2023 06:54 ET

Strong 3Q23 Results and Promising Clinical Developments Reinforce Buy Rating for Tempest Therapeutics

TipRanksNov 9, 2023 06:50 ET

Promising Prospects for Tempest Therapeutics: Buy Rating and Price Target Increase Based on Potential of TPST-1120

TipRanksOct 11, 2023 09:55 ET

HC Wainwright & Co. Maintains Buy on Tempest Therapeutics, Raises Price Target to $47

BenzingaOct 11, 2023 09:52 ET

Tempest Therapeutics Analyst Ratings

BenzingaOct 11, 2023 09:50 ET

Analysts Are Bullish on These Healthcare Stocks: Tempest Therapeutics (TPST), Icecure Medical (ICCM)

TipRanksOct 3, 2023 06:32 ET

Tempest Therapeutics Analyst Ratings

BenzingaAug 11, 2023 08:20 ET